Bioness Inc. Release: 42-Week Follow Up Study Shows Bioness L300 Foot Drop System Progressively Improves Walking In Stroke Survivors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. today announced that 42-week follow-up results from the company’s Functional Ambulation: Standard Treatment vs. Electrical Stimulation Therapy (FASTEST) trial of the Bioness L300® Foot Drop System have been published in the American Academy of Physical Medicine and Rehabilitation’s journal, PM&R. The study, titled “Response and Prediction of Improvement in Gait Speed from Functional Electrical Stimulation in Post-Stroke Drop Foot,” is an extension of the primary 30-week analysis demonstrating a similar impact with greater satisfaction when the L300® was compared to an ankle foot orthosis (AFO).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC